Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00004457|
Recruitment Status : Unknown
Verified January 2001 by Office of Rare Diseases (ORD).
Recruitment status was: Active, not recruiting
First Posted : October 19, 1999
Last Update Posted : June 24, 2005
I. Determine specific clinical features, molecular abnormalities, and laboratory-based biological markers of free radical stress that are associated with amyotrophic lateral sclerosis and influence disease severity.
|Condition or disease|
|Amyotrophic Lateral Sclerosis|
|Study Type :||Observational|
|Estimated Enrollment :||75 participants|
|Observational Model:||Defined Population|
|Study Start Date :||March 1998|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00004457
|Study Chair:||Merit E. Cudkowicz||Massachusetts General Hospital|